Lastet and interstitial lung disease Patient Reports February 09, 2010

Lastet Side Effects Report #5773704-6
Lastet side effect was reported by a Health Professional from JAPAN on June 11, 2008. Male patient, 34 years of age, was diagnosed with extragonadal primary germ cell cancer and was treated with Lastet. After drug was administered, patient experienced the following side effects: interstitial lung disease. Lastet dosage: 1ST+2ND CYCLE:180MG/DAY, TOTAL 900MG BETWEEN 26JUN-2JUL + 25JUL-29JUL IN 2006. During the same period patient was treated with BRIPLATIN, BLEOMYCIN. Patient recovered.

Lastet Side Effects Report #5796479-3
Lastet side effect was reported by a Health Professional from JAPAN on June 30, 2008. Male patient, 34 years of age, was diagnosed with extragonadal primary germ cell cancer and was treated with Lastet. After drug was administered, patient experienced the following side effects: interstitial lung disease. Lastet dosage: 1ST+2ND CYCLE:180MG/DAY, TOTAL 900MG BETWEEN 26JUN-2JUL + 25JUL-29JUL IN 2006. During the same period patient was treated with BRIPLATIN, BLEOMYCIN. Patient was hospitalized. Patient recovered.